Intensive Glycemic Control For Diabetic Foot Ulcer Healing
NCT04323462 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 326
Last updated 2021-11-02
Summary
With the available molecular and cellular evidence of impaired wound healing due to hyperglycemia, investigators postulate hypothesis asking whether intensive glycemic control could improve diabetic foot ulcer healing rates. A study showed improvement in phagocytic activity of macrophages after 5 days of intensive glycemic improvement in 21 patients of diabetes. Another retrospective cohort study studied the effect on HbA1c as predictor of healing rate in DFU. Latter found significant association of HbA1c with wound area healing rate. However a recent systematic review failed to find any randomized control trial comparing the effect of intensive versus conventional glycemic control for treating DFU. Hence, investigators want to explore the hypothesis by conducting a randomized control trial with the primary aim of wound healing in patients of diabetic foot ulcer in response to intensive glycemic control in comparison to conventional glycemic management.
Conditions
- Diabetic Foot Ulcer
Interventions
- DRUG
-
Insulin Glargine
Three times bolus insulin with regular or Shorter acting insulin
- DRUG
-
Diabetic DM
Previously receiving OADs and/or basal insulin
Sponsors & Collaborators
-
Institute of Post-Graduate Medical Education and Research, Kolkata
collaborator OTHER -
Jawaharlal Institute of Postgraduate Medical Education & Research
collaborator OTHER_GOV -
All India Institute of Medical Sciences, Bhubaneswar
collaborator OTHER -
Post Graduate Institute of Medical Education and Research, Chandigarh
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-01
- Primary Completion
- 2022-11-30
- Completion
- 2022-12-31
Countries
- India
Study Locations
More Related Trials
-
Local Application of Autologous Bone Marrow Cells for Treatment of Chronic Diabetic Ulcers
NCT00292357 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
NCT02427802 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)
NCT00700362 ·Status: WITHDRAWN
-
Shockwave Treatment of Diabetic Foot Ulcer: Step I
NCT00954343 ·Status: WITHDRAWN ·Phase: NA
-
Nutritional Supplement on Wound Healing in Diabetic Foot
NCT03679273 ·Status: UNKNOWN ·Phase: NA
-
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
NCT06852976 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
NCT00796744 ·Status: COMPLETED ·Phase: PHASE2
-
Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers
NCT00366132 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers
NCT00446472 ·Status: UNKNOWN ·Phase: NA
-
Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use
NCT01840085 ·Status: TERMINATED ·Phase: PHASE3
-
Predictive Analysis of Diabetic Foot Ulcer
NCT06768554 ·Status: ACTIVE_NOT_RECRUITING
-
PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer
NCT03248466 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Immunonutrition for Diabetic Foot Ulcers
NCT05281562 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Low Intensity Shockwave Therapy in Treating Diabetic Foot Ulcers
NCT02691234 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Use of Low-level Laser Therapy in the Treatment of Diabetic Foot Ulcers
NCT04246814 ·Status: COMPLETED ·Phase: NA
-
Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
NCT01830348 ·Status: TERMINATED ·Phase: PHASE3
-
The Regeneration Effects of Derma-PACE Shockwave in Chronic Diabetic Ulcers
NCT01219127 ·Status: UNKNOWN ·Phase: NA
-
Comparative Effectiveness of Two Acellular Matrices (Dermacell vs. Integra) for Management of Deep Diabetic Foot Ulcers
NCT03476876 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer
NCT06231771 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients
NCT00288392 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care
NCT03626623 ·Status: TERMINATED ·Phase: NA
-
Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics
NCT00967837 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
NCT01060670 ·Status: COMPLETED ·Phase: NA
-
Diabetic Foot Ulcer and Wound Infection
NCT03827902 ·Status: WITHDRAWN
-
Evaluate the Safety and Efficacy of RegenKit Autologous PRP Gel for the Treatment of Diabetic Foot Ulcer
NCT02402374 ·Status: UNKNOWN ·Phase: NA